Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
ACVRL1 encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. De plus, nous expédions ACVRL1 Anticorps (173) et ACVRL1 Protéines (26) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 30 products:
Results show that ALK5 (Montrer TGFBR1 Kits ELISA) and ALK1 play antagonistic roles in TGF-beta (Montrer TGFB1 Kits ELISA)-induced podosome formation in aortic endothelial cells.
ALK1 and ALK5 (Montrer TGFBR1 Kits ELISA) are both essential for correct regulation of VEGF (Montrer VEGFA Kits ELISA), and that disruption of either pathway leads to disease.
alk1 loss has no effect on arterial endothelial cell proliferation but alters arterial endothelial cell migration within lumenized vessels.
Control of Notch (Montrer NOTCH1 Kits ELISA) targets in arterial endothelium is context-dependent, with gene-specific and region-specific requirements for Notch (Montrer NOTCH1 Kits ELISA) and Alk1
Blood flow is required not only for alk1 expression but also for Alk1 activity.
Study demonstrate that alk1 expression requires blood flow, and despite normal levels of shear stress, some flow-responsive genes are dysregulated in alk1 mutant arterial endothelial cells.
vbg encodes activin receptor-like kinase 1 (acvrl1), a TGFbeta (Montrer TGFB1 Kits ELISA) type I receptor that is expressed predominantly in the endothelium of the vessels that become dilated in vbg mutants.
We have identified a novel role for ALK1 in cardiac remodeling
The present study showed that deletion-duplication mutations in the BMPR2 (Montrer BMPR2 Kits ELISA) or ACVRL1 genes may not be associated with non-regression of Pulmonary arterial hypertension.
Study identified 2 non-synonymous missense mutations: c.C652T, p.R218W in ACVRL1, c.C717G, p.D239E in SGCD (Montrer SGCD Kits ELISA) in Chinese population with total anomalous pulmonary venous return.
Mutations in ACVRL1 gene encoding for transforming growth factor (TGF)-[beta] superfamily have been identified in Pulmonary Arterial Hypertension.
Treatment-related telangiectasia was noted in 7% of patients, suggesting in vivo inhibition of the ALK-1 pathway.
Data indicate that simultaneous targeting of molecules that control distinct phases of angiogenesis, such as ALK1 and VEGFR, is a valid strategy for treatment of metastatic renal cell carcinoma (mRCC).
Study showed that rs706819, rs2293094, and rs11169953 polymorphisms in the ACVRL1 gene are associated with higher susceptibility to brain arteriovenous malformations.
c.1027C > T(p.Gln343) mutation within the ACVRL1 gene in family with hereditary hemorrhagic telangiectasia
Bone morphogenetic protein (BMP)9 (Montrer GDF2 Kits ELISA) and BMP10 (Montrer BMP10 Kits ELISA) are high affinity ligands for activin receptor-like kinase 1 (ALK1).
Activin receptor-like kinase (ALK)1 is a transforming growth factor beta (TGF-beta) type I receptor (Montrer TGFBR1 Kits ELISA) predominantly expressed in actively proliferating endothelial cells (ECs).
Data show that concomitant activin receptor-like kinase 1 (Acvrl1) and endoglin (Eng (Montrer ENG Kits ELISA)) deficiency synergistically decreases pancreatic neuroendocrine tumor volume.
Global deletion of AlK-1 is associated with the development of high output heart failure without maladaptive remodeling.
These data indicate that both Itgb8 and Alk1 are important in maintaining normal cerebral angiogenesis in response to VEGF (Montrer VEGFA Kits ELISA). Itgb8 deficiency enhances the formation of dysplastic vessels and hemorrhage in Alk1 (+/-) mice.
these studies characterize an accessory TGF-beta (Montrer TGFB1 Kits ELISA)-stimulated BMP R-Smad (Montrer SMAD1 Kits ELISA) signaling mechanism in interstitial cells of the developing lung.
this study demonstrates that ACVRL1 signaling plays a pivotal role whereby it suppresses plasmacytoid dendritic cell development while enhancing that of CD8alpha(+) dendritic cells, thus contributing to DC diversity development.
CD109 (Montrer CD109 Kits ELISA) differentially regulates TGF-beta (Montrer TGFB1 Kits ELISA)-induced ALK1-Smad1 (Montrer SMAD1 Kits ELISA)/5 versus ALK5 (Montrer TGFBR1 Kits ELISA)-Smad2 (Montrer SMAD2 Kits ELISA)/3 pathways, leading to decreased extracellular matrix production in the skin; epidermal CD109 (Montrer CD109 Kits ELISA) expression regulates dermal function through a paracrine mechanism
he results of the present study demonstrated that BMP9 (Montrer GDF2 Kits ELISA) promoted the osteoclast differentiation of osteoclast precursors via binding to the ALK1 receptor on the cell surface, and inhibiting the ERK1/2 (Montrer MAPK1/3 Kits ELISA) signaling pathways in the cell
Conclude that the ALK-1 receptor is involved in the control of arterial pressure. High AP of Alk1(+/-) mice is explained mainly by the sympathetic overactivation, which is probably related to the decreased number of cholinergic neurons.
Report interaction between ALK1 signaling and connexin40 in the development of arteriovenous malformations.
This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2.
activin A receptor type II-like 1
, serine/threonine-protein kinase receptor R3
, serine/threonine-protein kinase receptor R3-like
, activin receptor-like kinase 1
, violet beauregarde
, TGF-B superfamily receptor type I
, activin A receptor, type II-like kinase 1
, Activin receptor like kinase 1
, activin receptor-like kinase-1